Trial Profile
Comparison Examination of efficacy and safety of new 5-ASA with Salazosulfapyridine preparation for ulcerative colitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 02 Oct 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 03 Oct 2011 New trial record